The number of people impacted by long COVID continues to increase as physicians are beginning to understand how to identify these patients and develop a multi-disciplinary treatment plan to address the various symptoms.

TORONTO (PRWEB)
September 30, 2021

Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), commonly known as Long COVID, is a term used for patients that have recovered from acute COVID but have persistent symptoms lasting weeks or months. The number of people impacted by long COVID continues to increase as physicians are beginning to understand how to identify these patients and develop a multi-disciplinary treatment plan to address the various symptoms. In pursuit of answers, Labcorp is pleased to announce a webinar series devoted to the next pandemic, long COVID. In this series, the speakers will explore different topics specific to Long COVID that are impacting patients, physicians, as well as drug development companies.

In the first of our series, the speakers will explore the dizzying world of Postural Orthostatic Tachycardia Syndrome (POTS). POTS has traditionally been a highly symptomatic, potentially debilitating, often poorly understood medical condition and is notoriously a challenge to treat. Now, as a result of the COVID pandemic, a new light has been shone on POTS as the population of patients diagnosed with the condition continues to rise.

Join this webinar to hear from two key opinion leaders in the field as we explore symptoms, diagnosis and potential mechanisms for post-COVID POTS as well as consider a framework for therapy.

Join Artur Fedorowski, MD, PhD, Senior Consultant and Head of Syncope Unit, Dept. of Cardiology, Karolinska University Hospital; Brian Olshansky, MD, Clinical Cardiac Electrophysiologist, Carleton College and University of Arizona School of Medicine; and Oren Cohen, MD, Head of Clinical Pharmacology Services and Chief Medical Officer, Labcorp Drug Development, for the live webinar on Monday, October 18, 2021 at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit The Dizzying World of Post-COVID POTS: Symptoms, Potential Mechanisms and Therapies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

AdventHealth Belleview ER

“As our community grows, it’s imperative that we continue to grow and expand our services. We are excited about bringing our connected network of care to families in Belleview and The Villages,” said Joe Johnson, President and CEO of AdventHealth Ocala.

BELLEVIEW, Fla. (PRWEB)
September 30, 2021

Today, leaders at AdventHealth cut the ribbon on a new 13,000 square foot, 24-hour emergency room (ER) located at 6006 SE Abshier Blvd in Belleview, Florida. The 12-bed facility is a full-service ER and has the ability to transfer patients requiring an extended stay to AdventHealth Ocala for care if needed. The ER will officially open for care on Tuesday, October 12 at 9 am.

“As our community grows, it’s imperative that we continue to grow and expand our services. We are excited about bringing our connected network of care to families in Belleview and The Villages,” said Joe Johnson, President and CEO of AdventHealth Ocala. “With this new ER, we can provide our brand of whole person care to more families, fulfilling our promise to elevate care for everyone in the Greater Marion County community and beyond.”

The $18 million facility offers a wide array of services from board-certified emergency medicine physicians and nurses who specialize in emergency care for adults and children. Some of the services will include state of the art, on-site diagnostic imaging including x-ray, ultrasound, CT scans and onsite laboratory services to provide patients with real-time results – leading to more accurate and convenient diagnosis and treatment.

“AdventHealth Belleview ER will be home to some of the best doctors and nurses in emergency care,” said Dr. Michael Torres, Chief Medical Officer of AdventHealth Ocala. “Whether you’re having chest pain or a critical injury, we have the experts ready and waiting to care for you when you need us most.”

The new emergency room is expected to provide more than 50 jobs in Marion County.

This will be AdventHealth’s second offsite emergency room in Marion County. The hospital system also operates AdventHealth TimberRidge ER in Ocala.

About AdventHealth Ocala

AdventHealth Ocala is a 385-bed full-service community hospital that opened in 1898. In August 2018, AdventHealth Ocala became a part of the AdventHealth network. The facility is 640,000 square feet and sits on 15-acres. Within the hospital network there are two 24/7 ER facilities, one onsite and another offsite, to better meet the needs of Marion County. The onsite ER has both an adult and children’s emergency department that has over 50 combined beds with the ability to treat many conditions and injuries. Established in 2002, the offsite ER, AdventHealth TimberRidge ER, is a 24-hour full-service emergency department with 16 private rooms and was the first offsite ER in the state of Florida. The hospital offers many inpatient services including, labor and delivery through The Baby Place®, Orthopedic unit, comprehensive cardiovascular surgery unit, and a wound care center. AdventHealth Ocala is accredited The Joint Commission and has received recognition from American Heart Association and American Stroke Association. They are accredited by the American College of Cardiology in Chest Pain, Heart Failure, Cardiac Cath Lab, Electrophysiology, Transcatheter Valve Certified and awarded the HeartCARE™ Center designation. They are also a Certified Advanced Primary Stroke Center as well as a Center of Excellence in Robotic Surgery.

About AdventHealth West Florida Division

The West Florida Division of AdventHealth has some of the nation’s brightest medical minds making lifesaving breakthroughs with surgical pioneers, scientists and researchers using leading edge technology and innovation to deliver our brand of whole-person care. Our network of care includes AdventHealth Carrollwood, AdventHealth Connerton, AdventHealth Dade City, AdventHealth Lake Placid, AdventHealth North Pinellas, AdventHealth Ocala, AdventHealth Sebring, AdventHealth Tampa, AdventHealth Wauchula, AdventHealth Wesley Chapel and AdventHealth Zephyrhills, as well as five freestanding offsite Emergency Rooms including AdventHealth Brandon ER, AdventHealth Central Pasco ER, AdventHealth Palm Harbor ER, AdventHealth TimberRidge ER, and AdventHealth Westchase ER. We are more than hospitals, as we have a robust system of care including specialty acute care, over 200 primary care and specialty employed physicians, Express Care at Walgreens clinics, urgent care centers, wound care, physical therapy, home care, mobile mammography and more. AdventHealth is a faith-based not-for-profit health care system with a mission of Extending the Healing Ministry of Christ. AdventHealth has hundreds of care sites and nearly 50 hospitals across the United States. For more information about AdventHealth, visit AdventHealth.com, or Facebook.com/AdventHealth, and for West Florida Division.

Share article on social media or email:

The most critical step in the end is sample preparation, where best practices minimize the chance of sample contamination and degradation.

TORONTO (PRWEB)
September 30, 2021

qPCR testing is at its highest due to the COVID-19 pandemic and laboratory professionals should learn how to protect themselves from the associated safety and ergonomic challenges. Ensuring the wellbeing of laboratory workers and the DNA also yields the best and most accurate results. This webinar will educate participants on the common issues that qPCR testing laboratories face and will share best practices on avoiding contamination and improving the reproducibility of results.

Avoiding contaminants and ensuring nucleic acid quality are at the core of everyday work in a qPCR laboratory. How the laboratory layout and workflows are designed can reduce the chance of contamination and the choice of laboratory plastics has a surprising impact on the quality of the work. The most critical step in the end is sample preparation, where best practices minimize the chance of sample contamination and degradation.

Long hours in the lab doing precision work are tiring, which gives rise to human errors but also to common issues such as wrist strain and pain in the lower back. The effects can be reduced with attention to proper ergonomics by selecting proper tools and educating laboratory personnel on ergonomic work routines. By considering ergonomics in everyday laboratory work, variation in experiment results is reduced, employees stay focused and sick days are reduced.

Join Paulus Artimo, Product Manager, Sartorius, for the live webinar on Wednesday, October 6, 2021 at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Best Practices for Protecting Results and Employees in SARS-CoV-2 qPCR Testing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Last year we pledged to donate a portion of the sales towards the Arthritis Foundation, with a minimum contribution of $100,000. Today, we are ever so proud to announce we reached our goal to support scientific research and advocacy for people living with arthritis.

LOS ANGELES (PRWEB)
September 30, 2021

Chil Wellness, a new-generation wellness company that offers high-quality CBD products to assist others with a more healthy, active lifestyle, is closing its year-long relationship with Arthritis Foundation.

On October 1, 2020, Chil Wellness joined forces with the Arthritis Foundation to help people living with arthritis or pain find relief and elevate their quality of life. The year-long relationship successfully ended September 30, 2021.

“Last year we pledged to donate a portion of the sales towards the Arthritis Foundation, with a minimum contribution of $100,000,” said Kevin DeMeritt, founder of Chil Wellness. “Today, we are ever so proud to announce we reached our goal to support scientific research and advocacy for people living with arthritis.”

All Chil Wellness products are made-in-the-USA with full-spectrum hemp CBD extract, all-natural ingredients and uses Bio-Nano™ technology, which creates CBD molecules as small as 125nm in size; 700 times smaller than the width of a human hair. This unique technology allows for more advanced formulas to help the CBD work more effectively.

To learn more about Chil Wellness and its products, visit https://chilwellness.com.

About Arthritis Foundation

The Arthritis Foundation is the Champion of Yes. We lead the fight for the arthritis community and help conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. Our goal is to chart a winning course, guiding families in developing personalized plans for living a full life — and making each day another stride towards a cure.

About Chil Wellness

On a mission to help his daughter restore her active lifestyle, Kevin DeMeritt founded Chil Wellness to provide alternative ways to address the aches and discomfort from Juvenile Rheumatoid Arthritis that were robbing his daughter of joy with friends and family. Today, the CBD formulas and products that Chil Wellness has developed are the radiant outcome of love, and they haven’t stopped since. The company pledges to be transparent with its commitment to using only all-natural ingredients, CBD grown from socially responsible sources and 100% satisfaction guarantee or your money back. To learn more about Chil Wellness and its products, visit https://chilwellness.com.

Share article on social media or email:

In an industry notoriously resistant to systemic change, there are many opportunities to employ emerging technologies — to the great benefit of patients and research teams alike.

TORONTO (PRWEB)
September 30, 2021

Clinical trial enrollment is one of the earliest and most daunting challenges sponsors face. If sponsors and their partners successfully navigate enrollment, randomization concerns are quickly replaced by retention for the study’s duration. In an industry notoriously resistant to systemic change, there are many opportunities to employ emerging technologies — to the great benefit of patients and research teams alike.

Many clinical trial tasks are better suited to automation and a digital-first experience for patients. For sponsors, the benefits are multifold: cost savings, the elimination of transcription errors and freeing up site staff to focus on patient-centric protocol elements where a human touch significantly improves the patient experience.

Register for the live webinar on Tuesday, October 19, 2021, at 1 p.m. EDT to explore how to leverage emerging technologies to improve trial enrollment. Join Elligo’s Raj Sharma, Executive Director of Digital Strategy, who will share how to facilitate patient-led research through increased data access.

For more information, or to register for this event, visit Utilizing Cutting-Edge Technologies to Increase Clinical Trial Access and Drive Faster Enrollment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Children’s Health serves hundreds of thousands of pediatric patients every year, and it makes me proud that our members and community are able to make a difference for the kids.

DALLAS (PRWEB)
September 30, 2021

Kick-off the Halloween season with a fun and socially-distant fundraiser for a good cause. Individuals can BOO friends and neighbors starting October 1, 2021 by secretly leaving a BOO sign in their front yard. Once they’ve been BOOed, it’s their turn to BOO someone else. Instructions on how to join the fun are on the back of the sign and the goal is to have a BOO sign on every lawn in the neighborhood!

For only $20, members of the Dallas–Fort Worth metroplex can now reserve their BOO sign through Children’s Health http://www.childrens.com/boo. Individuals can find a pick-up location closest to them during checkout by searching the zip code of their home, work, or school address. They will then select a convenient pick-up date and time, and instructions on how to collect a reserved BOO sign will be in the confirmation email.

“We love sponsoring the BOO Yard Sign Challenge every year. As a mom, I’ve taken my sons to Children’s Health facilities. Those experiences made me more aware of how their technology and attention to detail make the kids feel special,” says Neighborhood Credit Union Senior Vice President of Marketing & Communications, Jessie Swendig. “Children’s Health serves hundreds of thousands of pediatric patients every year, and it makes me proud that our members and community are able to make a difference for the kids.”

Take part in the 2021 giving season and Neighborhood Credit Union will match donations dollar for dollar up to $25,000. Reserve a BOO Yard Sign now or visit Children’s Health at http://www.childrens.com/boo to donate and find ways to get involved in this amazing cause.

As an active part of the community for 91 years, Neighborhood Credit Union is a not-for-profit financial organization serving the state of Texas with branch locations in Collin, Dallas, Denton, Ellis, and Tarrant counties. With assets topping $1 billion, Neighborhood Credit Union has a continuously growing membership of 56,000. For more information, call (214) 748-9393 or visit our homepage.

Share article on social media or email:

Cancer Research & Oncology, October 6-7

YORBA LINDA, Calif. (PRWEB)
September 30, 2021

Yorba Linda, CA (September 30, 2021) – Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is hosting its Cancer Research & Oncology conference on October 6th and 7th, marking the 9th consecutive year. The two-day program continues to bring together well-renowned experts on the front lines of scientific discovery and advancement on a global basis.

Cancer Research & Oncology 2021 remains as a long-standing conference providing participants the unique opportunity to foster collaborations and gain valuable insight on emerging topics including cancer immunotherapy and novel cancer therapeutics, health disparities and how cancer impacts the unrepresented and underserved, integrating genetics into standard of care and precision medicine, and the role of evolution and evolutionary medicine in understanding the drug and radiation resistance of cancer.

Kicking off day one, Dr. Angelo Moore, Assistant Director, Office of Health Equity, Duke Cancer Institute, Adjunct Associate Professor, University of North Carolina at Chapel Hill, will share a keynote address describing the impact of social drivers of health and our current healthcare system have on health disparities, the importance of understanding historical contributions to health disparities, and action items to improve healthy equity.

“COVID-19 has turned our worlds upside down and forced many to stay at home and away from routine cancer screenings. COVID is here but so is cancer. COVID highlighted the health disparities for others to visually see; however, many of us in the cancer health disparity realm have known this for quite some time. Health disparities are rooted in systemic racism, systemic discrimination, and social drivers of health. It is important to know this history and talk about the negative impact on health for historically marginalized populations. And, to address health disparities, we must address these systems,” commented, Angelo Moore, PhD, Assistant Director, Community Outreach, Engagement, and Equity, Duke Cancer Institute.

Day two features keynote speaker, Dr. Nadine Barrett, Assistant Professor, Family Medicine and Community Health; Director, Center for Equity in Research, Duke Clinical Translational Science Institute exploring diversity, equity, and inclusion in cancer research: the promise of stakeholder engagement.

The informative agenda addresses new breakthroughs in cancer science, therapeutics, and critical data while prominent speakers reveal discussions on monitoring tumor microenvironment immunotherapeutic impact in heterogeneous cancer: prostate cancer, spatial transcriptomics and a novel therapeutic target B7-H3, early identification of target candidates for pancreatic adenocarcinoma immunotherapy, breast cancer health disparities in African American women, advances in high-throughput drug screening using hydrogels for 3D cell culture, neoantigen vaccines for personalized immunotherapy, genetics and prostate cancer disparities facing African Americans, and the chemotherapeutic potential of rosehip and sweet potato plant extracts in triple negative breast cancer, just to name a few.

“Over the past 8 years, Labroots’ Cancer Research & Oncology virtual event has become the leading annual meeting and a proven success in bringing innovative research and up-to-date developments to the scientific community,” said Greg Cruikshank, Chief Executive Officer of Labroots. “We are excited to share the same goal year after year of improving patient outcomes and treatments, driving the field for rapid development of novel immunotherapies, and advancing cancer research via our enlightening educational forum.”

Produced on Labroots’ signature platform, this online environment allows participants to connect seamlessly across desktop and mobile devices delivering a complete educational experience. Attendees will visit the lobby, equipped with leaderboard and gamification, auditorium, featuring live-streaming video webcasts (new feature – live chat during the scheduled presentations), poster hall to explore date and engage in live chat conversations, exhibit hall to interact with sponsors and view their recent contributions in the field, and a virtual lounge to make valuable connections with colleagues, including a social media wall and photo booth.

By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits. To register for the event, click here. Follow the conversation online by using #LRcancer.

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email: